Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphoma

Radiation Oncology Investigations

Volumn 7, Issue 3, 1999, Pages 186-191

  Aref, Amr ^a,b   Narayan, Samir ^a   Tekyi Mensah, Samuel ^a   Varterasian, Mary ^a   Dan, Maria ^a   Eilender, David ^a   Karanes, Chatchada ^a   Al Katib, Ayad ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy resistance; Non Hodgkin's lymphoma; Radiotherapy resistance

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; TREATMENT FAILURE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, INTERMEDIATE-GRADE; MALE; MIDDLE AGED; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033035480     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:3<186::AID-ROI8>3.0.CO;2-2     Document Type: Article

References (20)

1. Hoppe R. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer 1985; 55:2176-2183.
2. Hallahan DE, Farah R, Vokes EE, Bitran JD, Ultmann JE, Golomb HM, Weichselbaum RR. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys 1989;17: 767-771.
3. Levitt SH, Lee CK, Bloomfield CD, Frizzera G. The role of radiation therapy in the treatment of early stage large cell lymphoma. Hematol Oncol 1985;3:33-37.
4. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324: 1685-1690.
5. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 1996;88:890-899.
6. Marubini E, Valsecchi MG. Competing risks. In: Barnett V, editor. Analyzing survival data from clinical trials and observational studies. Chichester, UK: John Wiley & Sons; 1995, p 331-363.
7. Johansson L, Carlsson J, Nilsson K. Radiation sensitivity of human histiocytic lymphomas in vitro. Acta Radiol Oncol 1983;22:315-320.
8. FitzGerald TJ, McKenna M, Kase K, Daugherty C, Rothstein L, Greenberger JS. Effect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: evidence for heterogeneity. Int J Radiat Oncol Biol Phys 1986;12:69-73.
9. Song CW, Kim TH, Khan FM, Kersey JH, Levitt SH. Radiobiological basis of total body irradiation with different dose-rate and fractionation: repair capacity of hemopoietic cells. Int J Radiat Oncol Biol Phys 1981; 7:1695-1701.
10. Sutcliffe SB, Gospodarowicz MK, Bush RS, Brown TC, Chua T, Bean HA, Clark RM, Dembo A, Fitzpatrick PJ, Peters MV. Role of radiation therapy in localized non-Hodgkin's lymphoma. Radiother Oncol 1985; 4:211-223.
11. Tubiana M, Carde P, Burgers JM, Cosset JM, Van Glabbeke M, Somers R. Prognostic factors in non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 1986;12:503-514.
12. Kun LE, Cox JD, Komaki R. Patterns of failure in treatment of stage I and II diffuse malignant lymphoid tumors. Radiology 1981;141:791-794.
13. Jeffery GM, Mead GM, Whitehouse JM, Ryall RD. Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma. Br J Cancer 1991;64:933-937.
14. Glick JH, Kim K, Earle J, O'Connell MJ. An ECOG randomized phase III trial of CHOP vs. CHOP + radiotherapy (XRT) for intermediate grade early state Non-Hodgkin's lymphoma (NHL). J Clin Oncol, Proc ASCO 1995;14:391.
15. Fuks Z, Kaplan HS. Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. Radiology 1973;108:675-684.
16. Mundt AJ, Williams SF, Hallahan D. High-dose chemotherapy and stem cell rescue for aggressive non-Hodgkin's lymphoma: a pattern of failure and implications for involved-field radiotherapy. Int J Radiat Oncol Biol Phys 1997;39:617-625.
17. Phillips GL, Fay JW, Herzig RH et al. The treatment of progressive non-Hodgkin's lymphoma with intensive chemoradiotherapy and autologous marrow transplantation. Blood 1990;75:831-838.
18. Brasacchio R, Constine L, Rapoport A et al. Dose escalation of consolidation radiation therapy (involved-field) following autologous bone marrow transplant for recurrent Hodgkin's disease and lymphoma. Int J Radiat Oncol Biol Phys 1996;36:171.
19. Veninga T, Tribukait B, Lemstra W, Linder I, Sundius G. Non-effectivity of roentgen irradiation in an in vivo rapidly growing murine lymphosarcoma. Acta Radiol Oncol 1983;22:477-485.
20. Aref A, Narayan S, Mohammad R, Yudelev M, Al-Katib A. Chemoresistant intermediate grade non-Hodgkin's lymphoma is only moderately radiosensitive: a clinical and laboratory study. Blood 1997; 90(Suppl 1):191a (Abstract #845).